Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: A cross-sectional study

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Atashili, Julius ^a   Gaynes, Bradley N ^b   Pence, Brian W ^c   Tayong, Gladys ^d   Kats, Dmitry ^e   O'donnell, Julie K ^e   Ndumbe, Peter M ^a   Njamnshi, Alfred K ^f  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Bamenda Regional Hospital   (Cameroon)

^e University of North Carolina at Chapel Hill   (United States)

^f UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Antiretroviral therapy; Cameroon; Dementia; HIV; Screen

Indexed keywords

ADULT; ANTIVIRAL THERAPY; ARTICLE; CAMEROON; CLINICAL FEATURE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; PREVALENCE; SCORING SYSTEM; SCREENING; STRUCTURED QUESTIONNAIRE;

ADOLESCENT; ADULT; AGE FACTORS; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMEROON; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84880115294     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-86     Document Type: Article

References (24)

1. Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities. J Neuroimmune Pharmacol 2010, 5:294-309. 10.1007/s11481-010-9205-z, 2914283, 20396973.
2. McArthur JC, Brew BJ. HIV-associated neurocognitive disorders: is there a hidden epidemic?. AIDS 2010, 24:1367-1370. 10.1097/QAD.0b013e3283391d56, 20559041.
3. Husstedt IW, Reichelt D, Neuen-Jakob E, Kastner F, Einsiedel RV, Vielhaber B, Arendt G, Evers S, Hahn K. Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nerve System. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-inflammatory and Anti-Allergy Agents) 2009, 8:192-201.
4. Treisman GJ, Kaplin AI. Neurologic and psychiatric complications of antiretroviral agents. AIDS 2002, 16:1201-1215. 10.1097/00002030-200206140-00002, 12045485.
5. Robertson K, Liner J, Hakim J, Sankalé JL, Grant I, Letendre S, Clifford D, Diop AG, Jaye A, Kanmogne G, Njamnshi A, Langford TD, Weyessa TG, Wood C, Banda M, Hosseinipour M, Sacktor N, Nakasuja N, Bangirana P, Paul R, Joska J, Wong J, Boivin M, Holding P, Kammerer B, Van Rie A, Ive P, Nath A, Lawler K, Adebamowo C, et al. NeuroAIDS in Africa. J Neurovirol 2010, 16:189-202. 10.3109/13550284.2010.489597, 3549534, 20500018.
6. Njamnshi AK, Muna WE, Njamnshi DM, Yepnjio FN, Fonsah JY, de P, Djientcheu V. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon. J Acquir Immune Defic Syndr 2008, 49:393-397. 10.1097/QAI.0b013e318183a9df, 19186351.
7. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 2010, 10:60. 10.1186/1471-2377-10-60, 2912842, 20626870.
8. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457. 10.1016/S0140-6736(07)61602-X, 18064739.
9. Gaynes BN, Pence BW, Atashili J, O'Donnell J, Kats D, Ndumbe PM. Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS One 2012, 7:e41699. 10.1371/journal.pone.0041699, 3409230, 22860006.
10. Pence BW, Gaynes BN, Atashili J, O'Donnell JK, Tayong G, Kats D, Whetten R, Whetten K, Njamnshi AK, Ndumbe PM. Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord 2012, 143:208-213. 10.1016/j.jad.2012.05.056, 22840467.
11. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613. 10.1046/j.1525-1497.2001.016009606.x, 1495268, 11556941.
12. Kessler RC, Ustün TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004, 13:93-121. 10.1002/mpr.168, 15297906.
13. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005, 19:1367-1374.
14. Robbins RN, Remien RH, Mellins CA, Joska JA, Stein DJ. Screening for HIV-Associated Dementia in South Africa: Potentials and Pitfalls of Task-Shifting. AIDS Patient Care STDS 2011, 25:587-593. 10.1089/apc.2011.0154, 3210027, 21919734.
15. Holguin A, Banda M, Willen EJ, Malama C, Chiyenu KO, Mudenda VC, Wood C. HIV-1 Effects on Neuropsychological Performance in a Resource-Limited Country, Zambia. AIDS Behav 2011, 15:1895-1901. 10.1007/s10461-011-9988-9, 3314062, 21744118.
16. Patel VN, Mungwira RG, Tarumbiswa TF, Heikinheimo T, Van Oosterhout JJ. High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients. Int J STD AIDS 2010, 21:356-358. 10.1258/ijsa.2010.009554, 20498107.
17. Lawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, Steenhoff A. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc 2010, 13:15. 10.1186/1758-2652-13-15, 2876070, 20406460.
18. Waldrop-Valverde D, Nehra R, Sharma S, Malik A, Jones D, Kumar AM, Ownby RL, Wanchu A, Weiss S, Prabhakar S, Kumar M. Education effects on the International HIV Dementia Scale. J Neurovirol 2010, 16:264-267. 10.3109/13550284.2010.497808, 20578972.
19. Nitrini R, Caramelli P, Herrera E, Charchat-Fichman H, Porto CS. Performance in Luria's fist-edge-palm test according to educational level. Cogn Behav Neurol 2005, 18:211-214. 10.1097/01.wnn.0000195292.48422.d5, 16340394.
20. Singh D, Sunpath H, John S, Eastham L, Gouden R. The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts- a preliminary report. Afr J Psychiatry (Johannesbg) 2008, 11:282-286.
21. Skinner S, Adewale AJ, DeBlock L, Gill MJ, Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med 2009, 10:246-252. 10.1111/j.1468-1293.2008.00679.x, 19187172.
22. Robbins RN, Joska JA, Thomas KGF, Stein DJ, Linda T, Mellins CA, Remien RH. Exploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: the challenge and need for culturally valid screening tests in South Africa. Clin Neuropsychol 2013, 27:437-454. 10.1080/13854046.2012.759627, 23336183.
23. Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S. Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav 2010, 14:371-378. 10.1007/s10461-009-9538-x, 19326205.
24. Kanmogne GD, Muna WFT, De Djientcheu V, Njamnshi AK, Zoung-Kanyi Bissek AC, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, Fonsah JY, Kuate CT, Angwafor SA, Dema F, Njamnshi DM, Kouanfack C. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon. J Neurol Sci 2009, 285:149-153. 10.1016/j.jns.2009.06.043, 19631349.